Our understanding of the genetics of bipolar disorder (BD) is advancing at a rapid pace. An increasing number of risk-associated polymorphisms and variants are being found, many of which reside in intergenic, intronic and other non-coding sequences. A major challenge lies in designing testable hypotheses to elucidate the potential function of disease-associated non-coding DNA. Many of these sequences are thought to exert regulatory functions, including long-range enhancer elements physically interacting with transcription start sites separated along the linear genome, sometimes by many kilobases of DNA. This proposal aims to generate a high- resolution quantitative trait loci (QTL) map of open chromatin in discrete cellular populations (neurons and glia) derived from two human cortical brain regions relevant to the pathophysiology of BD. We will then leverage high resolution expression quantitative trait loci (eQTLs), mapped in the same samples and brain regions, to identify BD associated noncoding regions that are simultaneously associated with differential exposure of regulatory regions (open chromatin) and gene expression of nearby genes (eQTLs). Long-range enhancer- promoter interactions of genes potentially regulated by open chromatin sequences will be mapped in human postmortem brain tissue using chromosome conformation capture, an innovative approach in neuroepigenetics. Multiscale network models causally linked to BD will be developed based on existing BD- related large-scale molecular data and the high-impact, high-resolution, complementary datasets generated through the proposed studies. Using iPS-cell-derived cultures of human neuronal cell systems, we will employ high-throughput molecular and cellular screening assays to not only validate the actions of individual genes on molecular and cellular BD-associated processes, but also to validate the molecular networks identified in our studies. The multidimensional approach presented here provides a roadmap to place BD genetic risk variants in molecular contexts to help identify the underlying regulatory and expression mechanisms through which they act. As a service to the BD research community, we will provide dramatically improved general access to large- scale, multidimensional datasets, together with systems level analyses of these datasets.

Public Health Relevance

Bipolar disorder (BD) is a common, chronic, and often disabling disorder that affects 1-4% of the US population. Multiscale network models causally linked to BD will be developed based on existing BD-related large-scale molecular data and the high-resolution complementary epigenome datasets generated through the proposed work. We will explore functional chromatin loopings at risk-associated DNA variants and polymorphisms in brain tissue and use neuronal cells grown in culture from reprogrammed skin cells to validate the molecular networks predicted to drive BD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
3R01MH109677-03S1
Application #
9672250
Study Section
Genetics of Health and Disease Study Section (GHD)
Program Officer
Arguello, Alexander
Project Start
2016-08-01
Project End
2021-05-31
Budget Start
2018-08-20
Budget End
2019-05-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Psychiatry
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Miller, Michael L; Chadwick, Benjamin; Dickstein, Dara L et al. (2018) Adolescent exposure to ?9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons. Mol Psychiatry :
Fullard, John F; Hauberg, Mads E; Bendl, Jaroslav et al. (2018) An atlas of chromatin accessibility in the adult human brain. Genome Res 28:1243-1252
Wang, Daifeng; Liu, Shuang; Warrell, Jonathan et al. (2018) Comprehensive functional genomic resource and integrative model for the human brain. Science 362:
McKenzie, Andrew T; Wang, Minghui; Hauberg, Mads E et al. (2018) Brain Cell Type Specific Gene Expression and Co-expression Network Architectures. Sci Rep 8:8868
Li, Mingfeng; Santpere, Gabriel; Imamura Kawasawa, Yuka et al. (2018) Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science 362:
Guennewig, Boris; Bitar, Maina; Obiorah, Ifeanyi et al. (2018) THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry 8:89
An, Joon-Yong; Lin, Kevin; Zhu, Lingxue et al. (2018) Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder. Science 362:
Hauberg, Mads E; Fullard, John F; Zhu, Lingxue et al. (2018) Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls. Mol Psychiatry :
Kozlenkov, Alexey; Li, Junhao; Apontes, Pasha et al. (2018) A unique role for DNA (hydroxy)methylation in epigenetic regulation of human inhibitory neurons. Sci Adv 4:eaau6190
Zhu, Ying; Sousa, André M M; Gao, Tianliuyun et al. (2018) Spatiotemporal transcriptomic divergence across human and macaque brain development. Science 362:

Showing the most recent 10 out of 18 publications